 Connection
Timothy Jenkins to Bacteremia
This is a "connection" page, showing publications Timothy Jenkins has written about Bacteremia.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.235 |
|
|
|
-
Young HL, Valdez C, Listy B, Jenkins TC. Patient harm events: hospital-onset bacteremia vs CMS-reportable events. Infect Control Hosp Epidemiol. 2026 Jan; 47(1):91-93.
Score: 0.771
-
Mourad A, Nwafo N, Skalla L, Holland TL, Jenkins TC. Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Clin Infect Dis. 2025 02 05; 80(1):29-36.
Score: 0.732
-
Hojat LS, Bessesen MT, Huang M, Reid M, Knepper BC, Miller MA, Shihadeh KC, Fugit RV, Jenkins TC. Effectiveness of Shorter Versus Longer Durations of Therapy for Common Inpatient Infections Associated With Bacteremia: A Multicenter, Propensity-Weighted Cohort Study. Clin Infect Dis. 2020 12 15; 71(12):3071-3078.
Score: 0.550
-
Jenkins TC, McCollister BD, Sharma R, McFann KK, Madinger NE, Barron M, Bessesen M, Price CS, Burman WJ. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect Control Hosp Epidemiol. 2009 Mar; 30(3):233-41.
Score: 0.243
-
Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008 Apr 01; 46(7):1000-8.
Score: 0.228
-
Craig A, Shihadeh KC, Knepper BC, Miller W, Young HL, Aragon D, Jenkins TC. Antibiotic adherence and treatment completion associated with partial oral therapy versus all intravenous therapy in patients with serious Staphylococcus aureus infections. BMC Infect Dis. 2025 May 17; 25(1):714.
Score: 0.187
-
Soto CL, Hsu AJ, Lee JH, Dzintars K, Choudhury R, Jenkins TC, McCreary EK, Quartuccio KS, Stohs EJ, Zimmerman M, Tamma PD. Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study. Clin Infect Dis. 2024 01 25; 78(1):27-30.
Score: 0.170
-
Holland TL, Cosgrove SE, Doernberg SB, Jenkins TC, Turner NA, Boucher HW, Pavlov O, Titov I, Kosulnykov S, Atanasov B, Poromanski I, Makhviladze M, Anderzhanova A, Stryjewski ME, Assadi Gehr M, Engelhardt M, Hamed K, Ionescu D, Jones M, Saulay M, Smart J, Seifert H, Fowler VG. Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia. N Engl J Med. 2023 10 12; 389(15):1390-1401.
Score: 0.167
-
Holland TL, Raad I, Boucher HW, Anderson DJ, Cosgrove SE, Aycock PS, Baddley JW, Chaftari AM, Chow SC, Chu VH, Carugati M, Cook P, Corey GR, Crowley AL, Daly J, Gu J, Hachem R, Horton J, Jenkins TC, Levine D, Miro JM, Pericas JM, Riska P, Rubin Z, Rupp ME, Schrank J, Sims M, Wray D, Zervos M, Fowler VG. Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial. JAMA. 2018 09 25; 320(12):1249-1258.
Score: 0.118
-
Young H, Swartwood CJ, Jenkins TC, Belknap R. A successful strategy for the use of synergistic intravenous streptomycin in a hemodialysis patient with refractory Enterococcus faecalis bacteremia. J Infect Chemother. 2011 Oct; 17(5):698-9.
Score: 0.070
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|